Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
282 hedge funds and large institutions have $4.71B invested in Exact Sciences in 2017 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 89 increasing their positions, 102 reducing their positions, and 35 closing their positions.
46% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 35
29% more capital invested
Capital invested by funds: $3.65B → $4.71B (+$1.06B)
6% more funds holding
Funds holding: 266 → 282 (+16)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
3.35% less ownership
Funds ownership: 87.23% → 83.88% (-3.4%)
13% less repeat investments, than reductions
Existing positions increased: 89 | Existing positions reduced: 102
74% less call options, than puts
Call options by funds: $86.2M | Put options by funds: $332M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$111M |
| 2 |
BlackRock
New York
|
+$26M |
| 3 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
+$22.9M |
| 4 |
US Bancorp
Minneapolis,
Minnesota
|
+$19.3M |
| 5 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$18.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$51.8M |
| 2 |
JP Morgan Chase
New York
|
-$34.9M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$34.3M |
| 4 |
Renaissance Technologies
New York
|
-$31.9M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$23.7M |
EXAS Hedge Fund Activity: Q3 2017 in Review
282 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q3 2017, worth a combined $4.71B — up 29% from $3.65B a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new EXAS positions and 35 closed out — a net gain of 16 holders — while 89 added to existing stakes and 102 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $111M. The largest seller was UBS Group, cutting an estimated $51.8M.
- 282 institutional investors held Exact Sciences (EXAS) as of Q3 2017, up from 266 in Q2 2017.
- Funds reported $4.71B of Exact Sciences stock for Q3 2017, up 29% quarter-over-quarter.
- 51 funds opened new Exact Sciences positions in Q3 2017 and 35 closed out, a net change of +16 holders.
- The largest Exact Sciences buyer in Q3 2017 was Wellington Management Group, an estimated $111M added.
- The largest Exact Sciences seller in Q3 2017 was UBS Group, an estimated $51.8M sold.
Based on aggregated 13F filings for Q3 2017.